374 filings
Page 4 of 19
SC 13G/A
BNTX
BioNTech SE
14 Feb 23
BioNTech SE / ATHOS KG ownership change
6:06am
S-8
BNTX
BioNTech SE
13 Feb 23
Registration of securities for employees
5:06pm
S-8 POS
BNTX
BioNTech SE
13 Feb 23
Registration of securities for employees (post-effective amendment)
4:04pm
6-K
BNTX
BioNTech SE
10 Jan 23
Current report (foreign)
4:04pm
6-K
BNTX
BioNTech SE
10 Jan 23
BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and Development
9:07am
6-K
BNTX
BioNTech SE
22 Dec 22
BioNTech and Fosun Pharma Provide COVID-19 Vaccine Doses For Vaccination of German Expatriates in China
8:03am
6-K
BNTX
BioNTech SE
9 Dec 22
Pfizer and BioNTech Receive U.S. FDA Fast Track Designation
9:17am
6-K
BNTX
BioNTech SE
8 Dec 22
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years
5:27pm
6-K
BNTX
BioNTech SE
7 Dec 22
Current report (foreign)
5:39pm
6-K
BNTX
BioNTech SE
5 Dec 22
Current report (foreign)
8:48am
6-K
BNTX
BioNTech SE
30 Nov 22
BioNTech and Ryvu Therapeutics Enter into Global Collaboration to Develop and Commercialize Immuno-Modulatory Small Molecule Candidates
7:51am
6-K
BNTX
BioNTech SE
18 Nov 22
Current report (foreign)
7:43am
6-K
BNTX
BioNTech SE
16 Nov 22
Current report (foreign)
9:56pm
6-K
BNTX
BioNTech SE
10 Nov 22
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster
4:33pm
6-K
BNTX
BioNTech SE
10 Nov 22
Current report (foreign)
4:32pm
6-K
BNTX
BioNTech SE
7 Nov 22
Unaudited Interim Condensed Consolidated Financial Statements
6:24am
6-K
BNTX
BioNTech SE
7 Nov 22
BioNTech Announces Third Quarter 2022 Financial Results and Corporate Update
6:07am
6-K
BNTX
BioNTech SE
4 Nov 22
Current report (foreign)
5:00pm
20-F/A
2021 FY
BNTX
BioNTech SE
26 Oct 22
Annual report (foreign) (amended)
5:20pm
6-K
BNTX
BioNTech SE
19 Oct 22
Current report (foreign)
6:27pm